Drug Trends Part One: Evaluating Retail and Mail Order Prescriptions

Each year the Mitchell Pharmacy Solutions Drug Trends Series analysis the state of pharmacy trends in workers' comp. In part one of our series, we evaluate retail and mail order prescriptions.

Infographic Summary

The COVID outbreak created countless challenges that have continued to carry on through 2021 and now into 2022. The way we work has been influenced forever, and as such workers’ comp has seen a shift in claim volumes and in conjunction pharmacy trends in both retail and mail-order channels. Find out more in our infographic.

View this and future installments of our drug trends series here.




To view future installments of our drug trends series, click here.

Enlyte is the parent brand of Mitchell | Genex | Coventry, a leader in cost-containment technology, independent medical exams (IME), provider and specialty networks, case management services, pharmacy benefit and disability management. The three businesses have recently aligned their joint industry expertise and advanced technology solutions into a combined organization of nearly 6,000 associates committed to simplifying and optimizing property, casualty and disability claims processes and services.

More from Risk & Insurance

More from Risk & Insurance